Skip to Main Content

Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy (PTSD)

Conditions

Diseases of the Nervous System | Mental Health & Behavioral Research

Phase II

What is the purpose of this trial?

The purpose of this study is to combine a single infusion of Ketamine with 7-days of trauma focus psychotherapy to relieve post traumatic stress disorder (PTSD) symptoms more effectively. This treatment has the potential to produce a significant therapeutic effect that otherwise would take months to occur.

  • Trial with
    Yale University School of Medicine
  • Start Date
    03/09/2016
  • End Date
    10/31/2018
Trial Image

For more information about this study, contact:

Charles Gordon

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    02/22/2018
  • Study HIC
    #1509016530